DERIVO®
Mexico·Clase III·II.PROSTHESES, ORTHOSES AND FUNCTIONAL AIDS·EMERGO,S.DER.L.DE C.V.·Registered August 26, 2022EL DISPOSITIVO DE EMBOLIZACIÓN DERIVO® ESTÁINDICADO PARA EL TRATAMIENTO DE LOS ANEURISMASINTRACRANEALES,QUENOSEPUEDENTRATARCONOTRASTÉCNICASENDOVASCULARESOCUYOTRATAMIENTOCONOTRAS TÉCNICAS ENDOVASCULARES ONEUROQUIRÚRGICAS PRESENTAN UN MAYOR
THE DERIVATIVE® EMBOLIZATION DEVICE IS INDICATED FOR THE TREATMENT OF INTRACRANIAL ANEURYSMS, WHICH CANNOT BE TREATED WITH OTHER ENDOVASCULAR TECHNIQUES AND WHOSE TREATMENT WITH OTHER ENDOVASCULAR OR NEUROSURGICAL TECHNIQUES HAS A GREATER
- Risk Class / Clase de Riesgo
- Clase III
- Product Type (Spanish)
- II.PROTESIS,ÓRTESISYAYUDASFUNCIONALES
- Product Type (English)
- II.PROSTHESES, ORTHOSES AND FUNCTIONAL AIDS
- Trade Name (Spanish)
- DISPOSITIVO DE EMBOLIZACION
- Trade Name (English)
- EMBOLIZATION DEVICE
- Analysis ID
- 0845C2022 SSA
- Registration Date
- August 26, 2022
- Name (Spanish)
- EMERGO,S.DER.L.DE C.V.
- Name (English)
- EMERGO,S.DER. L.DE C.V.
Access comprehensive regulatory information for DERIVO® (DERIVO®) in the Mexico medical device market through Pure Global AI's free database. This Clase III medical device is registered under COFEPRIS analysis ID 0845C2022 SSA and manufactured by EMERGO,S.DER.L.DE C.V.. The device was registered on August 26, 2022.
This page provides complete registration details including product type (II.PROSTHESES, ORTHOSES AND FUNCTIONAL AIDS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.